Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note that publications are automatically filled in from PubMed (Revision: v3.3.2). Replaced the prior PubMed-based description with updated wording reflecting automatic listing (Revision: v3.2.0).SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding lapse notice banner that used to appear on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedUpdated the study location name from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'.SummaryDifference0.0%

- Check42 days agoChange DetectedNo substantial content changes detected between the screenshots; core sections such as Study Overview, Eligibility Criteria, and Locations appear unchanged. Only minor formatting differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.